Back to calendar
Cartesian Therapeutics, Inc. (RNAC) Earnings
RNAC reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.88
Actual EPS: $-1.46
EPS surprise: -67.86%
Company overview
Market Cap$252.4M
PriceUSD 8.59
EPS (TTM)-5.80
52-week high14.56
52-week low5.60
SectorHealth Technology
IndustryBiotechnology
Employees75